Xiaojie Wu - Institute of AntibioticsHuashan Hospital, Fudan University

基本信息

浏览量：134

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 107 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Safety, Tolerability, and Pharmacokinetics of a Novel Anti-Influenza Agent ZX-7101A Tablets in Healthy Chinese Participants: a First-in-human Phase I Clinical Study

Junzhen Wu,Qiong Wei,Yi Jin,Guoying Cao,Jicheng Yu,Xiaojie Wu,Xinyi Yang, Yilin Li,Mei Liu, Xiaoli Qin,Jingwen Ai, Yin Wang,Wenhong Zhang,Jing Zhang

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTSno. 1 (2025)

引用0浏览0WOS引用

Model-Informed Recommendation of Mavacamten Posology for Chinese Adults with Obstructive Hypertrophic Cardiomyopathy

Xiaojie Wu, Shilpa Puli,Nanye Chen,Zhuang Tian, Peiwen Hsu, Jing Sun,Cheng Lyu,Samira Merali,Jing Zhang

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2025)

引用0浏览0WOS引用

Claudin 18.2-Targeting Antibody–drug Conjugate CMG901 in Patients with Advanced Gastric or Gastro-Oesophageal Junction Cancer (KYM901): a Multicentre, Open-Label, Single-Arm, Phase 1 Trial

Dan-Yun Ruan,Fu-Rong Liu,Xiao-Li Wei,Su-Xia Luo,Zhi-Xiang Zhuang,Zhen-Ning Wang,Fu-Nan Liu,Yan-Qiao Zhang, Jian-Wei Yang,Zhen-Dong Chen,Yong-Sheng Wang,Jun-Ye Wang,Xiao-Hua Liang,Xiao-Jie Wu,Yu-Long Zheng, Jian Liu,Xi Shi,Rakesh Kumar,Wei Liu, Bo Chen

The Lancet Oncology (2025)

引用0浏览0WOS引用

Population Pharmacokinetics and Pharmacodynamics of HFB30132A, a Monoclonal Antibody Against SARS-CoV-2, in Healthy Chinese and US Subjects

Yuancheng Chen,Size Li, William Hedrich,Xiaojie Wu, Shanshan Li,Chao Qiu,Ke Lin,Xingchen Bian,Jinjie He,He Zhou,Francisco Adrian,Liang Schweizer,Jing Zhang

International Journal of Antimicrobial Agentspp.107439, (2025)

引用0浏览0WOS引用

A Phase I, Randomized, Placebo-Controlled Trial to Evaluate the Pharmacokinetics, Safety, and Tolerability of Nirsevimab in Healthy Chinese Adults

Xiaomeng Mao, Xiaohan Hua, Chengyi Wu, Xiaoyun Ge, Jie Zhang,Xiaojie Wu,Robert J. Kubiak,Ulrika Waehlby Hamren,Tonya Villafana, Georgios Christou, Jannine Green,Therese Takas, Yuwen Jin

CTS-CLINICAL AND TRANSLATIONAL SCIENCEno. 1 (2025)

引用0浏览0WOS引用

Pharmacokinetic, Pharmacokinetic/Pharmacodynamic, and Safety Investigations of Cefiderocol in Chinese Healthy Subjects

Chuhan Zhang, Shuyan Yu,Size Li,Xiaojie Wu,Qiong Wei,Jinjie He,Guoying Cao,Haijing Yang, Jingjing Wang, Kohei Fujitani,Takayuki Katsube,Jing Zhang, Honghong Dou

Advances in Therapyno. 5 (2025): 2285-2297

引用0浏览0WOS引用

First-in-human Study to Evaluate the Safety, Tolerability, and Population Pharmacokinetic/pharmacodynamic Target Attainment Analysis of FL058 Alone and in Combination with Meropenem in Healthy Subjects

Zhiwei Huang,Xinyi Yang,Yi Jin,Jicheng Yu,Guoying Cao,Jingjing Wang,Yingying Hu, Jingyi Dai,Jufang Wu,Qiong Wei, Yan Tian,Shuyan Yu, Xu Zhu,Xiaomeng Mao,Wei Liu,Hong Liang,Shansong Zheng, Yunfei Ju, Zenghua Wang,Jing Zhang,Xiaojie Wu

ANTIMICROBIAL AGENTS AND CHEMOTHERAPYno. 1 (2024)

引用2浏览0WOS引用

Lefamulin Dosing Optimization Using Population Pharmacokinetic and Pharmacokinetic/pharmacodynamic Assessment in Chinese Patients with Community-Acquired Bacterial Pneumonia

Xingchen Bian,Nanyang Li,Yi Li, Xu Zhu,Jicheng Yu,Yingying Hu,Haijing Yang,Qiong Wei,Xiaojie Wu,Jingjing Wang,Guoying Cao,Jufang Wu, Yang Wang,Jing Zhang

FRONTIERS IN PHARMACOLOGY (2024)

引用0浏览0WOS引用

Pharmacokinetics and Safety of Mavacamten in Healthy Chinese Participants with Different CYP2C19 Phenotypes

Xiaojie Wu,Nanye Chen, Peiwen Hsu, Jing Sun, Wenting Li, Qi Wang,Merali Samira,Qiong Wei,Jicheng Yu,Guoying Cao,Haijing Yang,Lili Wang,Jingjing Wang,Yi Jin, Wei Liu,Jufang Wu,Jinjie He,Cheng Lyu,Jing Zhang

CTS-CLINICAL AND TRANSLATIONAL SCIENCEno. 7 (2024)

引用1浏览0WOS引用

Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of HLX14 Versus Reference Denosumab in Healthy Males: A Randomized Phase I Study

Nanyang Li,Nannan Chu,Leilei Zhu,Xiaojie Wu,Qiong Wei, Jiahui Wang, Xuhui Hu,Haoyu Yu, Qingyu Wang, Wei'an Yuan,Kai Huang,Jing Zhang

CTS-CLINICAL AND TRANSLATIONAL SCIENCEno. 12 (2024)

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn